Search filters

List of works by Arne Kolstad

"In situ" vaccination for systemic effects in follicular lymphoma

scientific article published on 19 March 2015

15-year follow-up of the Second Nordic Mantle Cell Lymphoma trial (MCL2): prolonged remissions without survival plateau

scientific article published on 5 July 2016

A national study on conditional survival, excess mortality and second cancer after high dose therapy with autologous stem cell transplantation for non-Hodgkin lymphoma

scientific article

Allogeneic stem-cell transplantation in adults 1985-2012: results and development

scientific article published on 2 September 2014

Altered BCR and CD40 signalling are associated with clinical outcome in small lymphocytic lymphoma/chronic lymphocytic leukaemia and marginal zone lymphoma patients

scientific article published on 09 October 2012

Biodistribution and dosimetry results from a phase 1 trial of (177)Lu-lilotomab satetraxetan antibody-radionuclide conjugate therapy

scientific article published on 28 August 2017

Cancer patients undergoing chemotherapy show adequate serological response to vaccinations against influenza virus and Streptococcus pneumoniae

scientific article published in January 2002

Clonal hematopoiesis evolves from pre-treatment clones and stabilizes after end of chemotherapy in patients with MCL

scientific article published on 16 March 2020

Computerized image analysis of the Ki-67 proliferation index in mantle cell lymphoma

scientific article

Conditional survival and excess mortality after high-dose therapy with autologous stem cell transplantation for adult refractory or relapsed Hodgkin lymphoma in Norway

scientific article published on 14 February 2015

Content of endothelial progenitor cells in autologous stem cell grafts predict survival after transplantation for multiple myeloma

scientific article

Detailed Long-Term Follow-Up of Patients Who Relapsed After the Nordic Mantle Cell Lymphoma Trials: MCL2 and MCL3

scientific article published on 21 December 2020

Distinct patterns of B-cell receptor signaling in non-Hodgkin lymphomas identified by single-cell profiling

scientific article

FDG PET/CT parameters and correlations with tumor-absorbed doses in a phase 1 trial of 177Lu-lilotomab satetraxetan for treatment of relapsed non-Hodgkin lymphoma

scientific article published on 16 November 2020

Hepatitis B virus-infected peripheral blood progenitor cell harvests in liquid nitrogen freezer containing non-infectious products

scientific article published in June 2004

High PD-1 expression and suppressed cytokine signaling distinguish T cells infiltrating follicular lymphoma tumors from peripheral T cells.

scientific article published on 7 January 2013

High dose chemotherapy with autologous stem cell support for patients with histologically transformed B-cell non-Hodgkin lymphomas. A Norwegian multi centre phase II study

scientific article published on 17 January 2011

High dose chemotherapy with autologous stem cell transplant for patients with transformed B-cell non-Hodgkin lymphoma in the rituximab era

scientific article published on 19 March 2014

High dose cytarabine with rituximab is not enough in first-line treatment of mantle cell lymphoma with high proliferation: early closure of the Nordic Lymphoma Group Mantle Cell Lymphoma 5 trial ⬇️

scientific article published on August 28, 2013

High-dose therapy with autologous stem cell support for lymphoma in Norway 1987-2008.

scientific article published in September 2013

High-dose therapy with autologous stem cell support for lymphoma--from experimental to standard treatment

scientific article published in September 2013

Ibrutinib, lenalidomide, and rituximab in relapsed or refractory mantle cell lymphoma (PHILEMON): a multicentre, open-label, single-arm, phase 2 trial

scientific article published on 29 January 2018

Immune-related protein signature in serum stratify relapsed mantle cell lymphoma patients based on risk

scientific article published on 07 December 2020

Is there a role for antigen selection in mantle cell lymphoma? Immunogenetic support from a series of 807 cases

scientific article published on 26 July 2011

KMT2D mutations and TP53 disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL study

scientific article published on 19 September 2019

Lenalidomide plus bendamustine-rituximab does not overcome the adverse impact of mutations in mantle cell lymphoma

scientific article published on 24 May 2018

Lenalidomide-bendamustine-rituximab in patients older than 65 years with untreated mantle cell lymphoma.

scientific article published on 27 June 2016

Long-term outcome for patients with early stage marginal zone lymphoma and mantle cell lymphoma

Long-term outcome of patients with solitary plasmacytoma treated with radiotherapy: A population-based, single-center study with median follow-up of 13.7 years

scientific article

Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo-purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group

scientific article

Mantle cell lymphoma - does primary intensive immunochemotherapy improve overall survival for younger patients?

scientific article published on August 2009

Mass Cytometry of Follicular Lymphoma Tumors Reveals Intrinsic Heterogeneity in Proteins Including HLA-DR and a Deficit in Nonmalignant Plasmablast and Germinal Center B-Cell Populations

scientific article published on 9 December 2016

Molecular Monitoring after Autologous Stem Cell Transplantation and Preemptive Rituximab Treatment of Molecular Relapse; Results from the Nordic Mantle Cell Lymphoma Studies (MCL2 and MCL3) with Median Follow-Up of 8.5 Years.

scientific article published on 27 December 2016

Molecular cytogenetic characterization of t(14;19)(q32;p13), a new recurrent translocation in B cell malignancies

scientific article published on 04 April 2007

Multimodal treatment with ALL-like chemotherapy, Auto-SCT and radiotherapy for lymphoblastic lymphoma

scientific article published on 18 November 2013

Myeloid cell leukaemia 1 has a vital role in retinoic acid-mediated protection of Toll-like receptor 9-stimulated B cells from spontaneous and DNA damage-induced apoptosis

scientific article published on 9 June 2016

Nordic MCL2 trial update: six-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC + autologous stem-cell support: still very long survival but late relapses do occur

scientific article published on 29 May 2012

Nordic MCL3 study: 90Y-ibritumomab-tiuxetan added to BEAM/C in non-CR patients before transplant in mantle cell lymphoma

scientific article

Persistent changes in the immune system 4-10 years after ABMT.

scientific article published in October 1999

Phase 1/2a study of 177Lu-lilotomab satetraxetan in relapsed/refractory indolent non-Hodgkin lymphoma

scientific article published on 01 September 2020

Phospho-specific flow cytometry identifies aberrant signaling in indolent B-cell lymphoma

scientific article

Pneumocystis jirovecii pneumonia in B-cell lymphoma patients treated with the rituximab-CHOEP-14 regimen.

scientific article published in January 2007

Pre-emptive treatment with rituximab of molecular relapse after autologous stem cell transplantation in mantle cell lymphoma.

scientific article

Preclinical development of CD37CAR T-cell therapy for treatment of B-cell lymphoma

article

Primary treatment with autologous stem cell transplantation in mantle cell lymphoma: outcome related to remission pretransplant

scientific article published in August 2003

Radiotherapy Compared to Other Strategies in the Treatment of Stage I/II Follicular Lymphoma: A Study of 404 Patients with a Median Follow-Up of 15 Years

scientific article

Red Marrow-Absorbed Dose for Non-Hodgkin Lymphoma Patients Treated with 177Lu-Lilotomab Satetraxetan, a Novel Anti-CD37 Antibody-Radionuclide Conjugate

scientific article

Rituximab blocks protective serologic response to influenza A (H1N1) 2009 vaccination in lymphoma patients during or within 6 months after treatment

scientific article

SOX11 and TP53 add prognostic information to MIPI in a homogenously treated cohort of mantle cell lymphoma--a Nordic Lymphoma Group study

scientific article

Sequential intranodal immunotherapy induces antitumor immunity and correlated regression of disseminated follicular lymphoma

scientific article published on 7 October 2014

Should alternative therapists treat cancer--what is the opinion of oncology health personnel?

scientific article published on 01 November 2003

T cells expressing checkpoint receptor TIGIT are enriched in follicular lymphoma tumors and characterized by reversible suppression of T-cell receptor signaling

scientific article published on 7 December 2017

T cells raised against allogeneic HLA-A2/CD20 kill primary follicular lymphoma and acute lymphoblastic leukemia cells

scientific article published on 12 August 2011

TIGIT and PD-1 Mark Intratumoral T Cells with Reduced Effector Function in B-cell Non-Hodgkin Lymphoma

scientific article published on 18 January 2019

TP53 mutations identify younger mantle cell lymphoma patients who do not benefit from intensive chemoimmunotherapy

scientific article published on 17 August 2017

Targeting B-cell neoplasia with T-cell receptors recognizing a CD20-derived peptide on patient-specific HLA

scientific article published on 18 February 2016

The MCL35 gene expression proliferation assay predicts high-risk MCL patients in a Norwegian cohort of younger patients given intensive first line therapy

scientific article published on 06 August 2018

The Mantle Cell Lymphoma International Prognostic Index (MIPI) is superior to the International Prognostic Index (IPI) in predicting survival following intensive first-line immunochemotherapy and autologous stem cell transplantation (ASCT).

scientific article published on 23 December 2009

Therapeutic effect of CD137 immunomodulation in lymphoma and its enhancement by Treg depletion

scientific article published on 29 July 2009

Tumor-Absorbed Dose for Non-Hodgkin Lymphoma Patients Treated with the Anti-CD37 Antibody Radionuclide Conjugate 177Lu-Lilotomab Satetraxetan

scientific article published on 4 August 2016

Use of Alternative Medicine Among Norwegian Cancer Patients is Associated with Mental Distress - A Follow-up Study

scientific article published in January 2002

[Alternative medicine--attitudes and use among physicians, nurses and administrative staff employed in hospitals in northern Norway]

scientific article published on 01 March 2003

[Can the immune system target cancer?]

scientific article published on 01 April 2012

[Mental distress and use of alternative medicine among cancer patients]

scientific article published on 01 March 2003

[Should complementary therapies be offered in hospitals?]

scientific article published on 01 December 2004

miR-18b overexpression identifies mantle cell lymphoma patients with poor outcome and improves the MIPI-B prognosticator

scientific article

p53 is associated with high-risk and pinpoints TP53 missense mutations in mantle cell lymphoma

scientific article published on 04 August 2020

Paulina is supported by:

About Paulina

Help